Terms: = Liver cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
1861 results:
1. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study.
Chiloiro G; Panza G; Boldrini L; Romano A; Placidi L; Nardini M; Galetto M; Votta C; Campitelli M; Cellini F; Massaccesi M; Gambacorta MA
Radiat Oncol; 2024 Apr; 19(1):52. PubMed ID: 38671526
[TBL] [Abstract] [Full Text] [Related]
2. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
4. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
5. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
6. HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study.
Chang X; Li X; Sun P; Li Z; Sun P; Ning S
BMC Cancer; 2024 Apr; 24(1):480. PubMed ID: 38627684
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
8. Uveal melanoma cell lines Mel270 and 92.1 exhibit a mesenchymal phenotype and sensitivity to the cytostatic effects of transforming growth factor beta in vitro.
Doudnikoff C; Leclerc D; Angenard G; Gilot D; Coulouarn C; Mouriaux F
Mol Vis; 2024; 30():160-166. PubMed ID: 38601020
[TBL] [Abstract] [Full Text] [Related]
9. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
[TBL] [Abstract] [Full Text] [Related]
10. Association of the Advanced Lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
Jiang H; Li B; Wu M; Wang Q; Li Y
BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
[TBL] [Abstract] [Full Text] [Related]
11. Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.
Miuma S; Miyaaki H; Ichikawa T; Matsuzaki T; Goto T; Kamo Y; Shigeno M; Hino N; Ario K; Yanagi K; Tsutsumi T; Fukushima N; Nakashiki S; Yamasaki K; Hamasaki K; Shibata H; Arima K; Yamamichi S; Yamashima M; Takahashi K; Nakao Y; Fukushima M; Haraguchi M; Sasaki R; Ozawa E; Taura N; Nakao K
J Med Virol; 2024 Mar; 96(3):e29432. PubMed ID: 38509793
[TBL] [Abstract] [Full Text] [Related]
12. REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M; Desideri I; Villani V; Simonelli M; Buglione M; Chiesa S; Franceschi E; Gaviani P; Stasi I; Caserta C; Brugnara S; Lolli I; Bennicelli E; Bini P; Cuccu AS; Scoccianti S; Padovan M; Gori S; Bonetti A; Giordano P; Pellerino A; Gregucci F; Riva N; Cinieri S; Internò V; Santoni M; Pernice G; Dealis C; Stievano L; Paiar F; Magni G; De Salvo GL; Zagonel V; Lombardi G
ESMO Open; 2024 Apr; 9(4):102943. PubMed ID: 38492275
[TBL] [Abstract] [Full Text] [Related]
13. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
Wang C; Wang J; Qi Y
J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
Kinami T; Uchikawa S; Kawaoka T; Yamasaki S; Kosaka M; Johira Y; Yano S; Amioka K; Naruto K; Yamaoka K; Fujii Y; Fujino H; Nakahara T; Ono A; Murakami E; Okamoto W; Yamauchi M; Miki D; Tsuge M; Oka S
Cancer Med; 2024 Mar; 13(5):e7025. PubMed ID: 38477514
[TBL] [Abstract] [Full Text] [Related]
15. Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan.
Yamashita T; Suzuki N; Motoyoshi K; Zhu W; Furuse J
PLoS One; 2024; 19(3):e0298420. PubMed ID: 38457389
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of the first HBV qRT-PCR assay in the Mediterranean area targeting the X region.
Madihi S; Laassili C; Boukaira S; Baha W; Khyatti M; Zyad A; Ben Mkaddem S; Benani A
J Virol Methods; 2024 May; 326():114913. PubMed ID: 38452821
[TBL] [Abstract] [Full Text] [Related]
17. Mid- to long-term outcome of laparoscopic ultrasound-guided radiofrequency ablation for malignant hepatic tumors.
Chern MC; Lin CW; Lin ZH; Tsai TJ
J Gastrointest Surg; 2024 Feb; 28(2):103-107. PubMed ID: 38445930
[TBL] [Abstract] [Full Text] [Related]
18. [Ultrasound-guided percutaneous thermal ablation assisted by artificial ascites and soft tissue edema in the treatment of special-region hepatic tumors].
Feng L; Wang Y; Niu LJ
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):155-160. PubMed ID: 38418190
[No Abstract] [Full Text] [Related]
19. A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.
Tirgar Fakheri S; Shokri-Afra H; Graham DY; Bari Z; Fakheri H
Helicobacter; 2024; 29(1):e13061. PubMed ID: 38411303
[TBL] [Abstract] [Full Text] [Related]
20. Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism.
Yellurkar ML; Prasanna VS; Das P; Sarkar S; Matta R; Dhaked DK; Peraman R; Taraphdar AK; Nanjappan SK; Velayutham R; Arumugam S
J Ethnopharmacol; 2024 May; 326():117935. PubMed ID: 38408692
[TBL] [Abstract] [Full Text] [Related]
[Next]
